-
ICD-10-CM Codes
›
-
E00-E89
›
-
E70-E88
›
-
E84-
›
-
2023 ICD-10-CM Diagnosis Code E84.9
2023 ICD-10-CM Diagnosis Code E84.9
Cystic fibrosis, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- E84.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM E84.9 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E84.9 - other international versions of ICD-10 E84.9 may differ.
The following code(s) above
E84.9 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
E84.9:
- E00-E89
2023 ICD-10-CM Range E00-E89
Endocrine, nutritional and metabolic diseasesNote- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Type 1 Excludes- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Endocrine, nutritional and metabolic diseases - E70-E88
2023 ICD-10-CM Range E70-E88
Metabolic disordersType 1 Excludes- androgen insensitivity syndrome (E34.5-)
- congenital adrenal hyperplasia (E25.0)
- hemolytic anemias attributable to enzyme disorders (D55.-)
- Marfan's syndrome (Q87.4)
- 5-alpha-reductase deficiency (E29.1)
Type 2 Excludes- Ehlers-Danlos syndromes (Q79.6-)
Metabolic disorders - E84
ICD-10-CM Diagnosis Code E84
Cystic fibrosis
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Code Also- exocrine pancreatic insufficiency (K86.81)
Cystic fibrosis
Approximate Synonyms
Clinical Information
- A common hereditary disease in which exocrine (secretory) glands produce abnormally thick mucus. This mucus can cause problems in digestion, breathing, and body cooling.
- A congenital metabolic disorder affecting the exocrine glands, inherited as an autosomal trait. The secretions of exocrine glands are abnormal, resulting in excessively viscid mucus production which causes obstruction of passageways (including pancreatic and bile ducts, intestines, and bronchi). The sweat sodium and chloride content are increased. Symptoms usually appear in childhood and include meconium ileus, poor growth despite good appetite, malabsorption and foul bulky stools, chronic bronchitis with cough, recurrent pneumonia, bronchiectasis, emphysema, clubbing of the fingers, and salt depletion in hot weather.
- An autosomal recessive genetic disease of the exocrine glands. It is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator expressed in several organs including the lung, the pancreas, the biliary system, and the sweat glands. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in airway obstruction; chronic respiratory infections; pancreatic insufficiency; maldigestion; salt depletion; and heat prostration.
- Cystic fibrosis (cf) is an inherited disease of the mucus and sweat glands. It affects mostly your lungs, pancreas, liver, intestines, sinuses and sex organs. Cf causes your mucus to be thick and sticky. The mucus clogs the lungs, causing breathing problems and making it easy for bacteria to grow. This can lead to problems such as repeated lung infections and lung damage. The symptoms and severity of cf vary widely. Some people have serious problems from birth. Others have a milder version of the disease that doesn't show up until they are teens or young adults. Although there is no cure for cf, treatments have improved greatly in recent years. Until the 1980s, most deaths from cf occurred in children and teenagers. Today, with improved treatments, some people who have cf are living into their forties, fifties, or older.
- Most common potentially lethal autosomal recessive disease affecting caucasians; characterized by chronic pulmonary, intestinal, liver, pancreatic, and exocrine gland dysfunction; caused by mutations of the cftr chloride channel.
ICD-10-CM E84.9 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 640 Miscellaneous disorders of nutrition, metabolism, fluids and electrolytes with mcc
- 641 Miscellaneous disorders of nutrition, metabolism, fluids and electrolytes without mcc
Convert E84.9 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to E84.9:
- Disease, diseased - see also Syndrome
- pancreas K86.9
ICD-10-CM Diagnosis Code K86.9
Disease of pancreas, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- Fibrocystic
- Fibrosis, fibrotic
- Jaundice (yellow) R17
ICD-10-CM Diagnosis Code R17
Unspecified jaundice
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- newborn P59.9
ICD-10-CM Diagnosis Code P59.9
Neonatal jaundice, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Code on Newborn Record
Applicable To- Neonatal physiological jaundice (intense)(prolonged) NOS
- Mucoviscidosis E84.9
ICD-10-CM Codes Adjacent To E84.9
E83.8 Other disorders of mineral metabolism
E83.89 Other disorders of mineral metabolism
E83.9 Disorder of mineral metabolism, unspecified
E84.0 Cystic fibrosis with pulmonary manifestations
E84.1 Cystic fibrosis with intestinal manifestations
E84.11 Meconium ileus in cystic fibrosis
E84.19 Cystic fibrosis with other intestinal manifestations
E84.8 Cystic fibrosis with other manifestations
E84.9
Cystic fibrosis, unspecified
E85.0 Non-neuropathic heredofamilial amyloidosis
E85.1 Neuropathic heredofamilial amyloidosis
E85.2 Heredofamilial amyloidosis, unspecified
E85.3 Secondary systemic amyloidosis
E85.4 Organ-limited amyloidosis
E85.81 Light chain (AL) amyloidosis
E85.82 Wild-type transthyretin-related (ATTR) amyloidosis
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.